Search

everythinglearnresearchcommunity

for

Search:↓

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Alopecia areata involves unique activation of certain immune cells.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

B cells can both help and hinder the body's defense against melanoma.

The research identified a gene in sheep important for wool quality, which could help improve wool traits.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Belatacept may be a promising treatment for alopecia areata.

CD200 is not a reliable marker for identifying stem cells in all skin types.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

Anti-CD19 therapy may help treat SLE and NMOSD.

CDK4 levels affect the number of hair follicle stem cells in mice.

VDAC2 promotes cell death in cashmere goat hair follicles through the P53 pathway.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.